|
[1]
|
Ensrud, K.E. and Crandall, C.J. (2018) Osteoporosis. Annals of Internal Medicine, 168, 306-307.
|
|
[2]
|
Weersma, R.K., Zhernakova, A. and Fu, J. (2020) Interaction between Drugs and the Gut Microbiome. Gut, 69, 1510- 1519. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Seely, K.D., Kotelko, C.A., Douglas, H., et al. (2021) The Human Gut Microbiota: A Key Mediator of Osteoporosis and Osteogenesis. International Journal of Molecular Sciences, 22, Article No. 9452. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
陈赛楠, 吴华嵩, 程佑民, 等. 续苓健骨方对去卵巢骨质疏松模型大鼠血液钙磷代谢的影响[J]. 中国骨质疏松杂志, 2019, 25(4): 528-532.
|
|
[5]
|
陈娟, 陈赛楠, 叶云金, 等. 续苓健骨汤含药血清对MC3T3-E1细胞分化及增殖的影响[J]. 中国骨质疏松杂志, 2019, 25(11): 1545-1549.
|
|
[6]
|
葛继荣, 李生强, 陈娟, 等. 续苓健骨方对骨质疏松模型大鼠骨密度及OPG和RANKL蛋白表达的影响[J]. 中国骨质疏松杂志, 2016, 22(5): 592-595.
|
|
[7]
|
Yousefzadeh, N., Kashfi, K., Jeddi, S., et al. (2020) Ovariectomized Rat Model of Osteoporosis: A Practical Guide. EXCLI Journal, 19, 89-107.
|
|
[8]
|
Cheng, T.Y., Li, J.X., Chen, J.Y., et al. (2021) Gut Microbiota: A Potential Target for Traditional Chinese Medicine Intervention in Coronary Heart Disease. Chinese Medicine, 16, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
赵进东, 余婵娟, 陆瑞敏, 等. 肠道菌群与骨质疏松症中西医研究进展[J]. 中国骨质疏松杂志, 2018, 24(12): 1676- 1680.
|
|
[10]
|
Locantore, P., Del, G.V., Gelli, S., et al. (2020) The Interplay between Immune System and Microbiota in Osteoporosis. Mediators of Inflammation, 2020, Article ID: 3686749. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Ibanez, L., Rouleau, M., Wakkach, A., et al. (2019) Gut Microbiome and Bone. Joint Bone Spine, 86, 43-47. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Cox, L.M., Yamanishi, S., Sohn, J., et al. (2014) Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences. Cell, 158, 705-721. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Britton, R.A., Irwin, R., Quach, D., et al. (2014) Probiotic L. reuteri Treatment Prevents Bone Loss in a Menopausal Ovariectomized Mouse Model. Journal of Cellular Physiology, 229, 1822-1830. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Pronovost, G.N. and Hsiao, E.Y. (2019) Perinatal Interactions between the Microbiome, Immunity, and Neurodevelopment. Immunity, 50, 18-36. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
D’Amelio, P. and Sassi, F. (2018) Gut Microbiota, Immune System, and Bone. Calcified Tissue International, 102, 415- 425. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
张钰涵, 梅其炳, 牛银波. 短链脂肪酸调控骨代谢的作用及机制的研究进展[J]. 微生物学通报, 2021, 48(11): 4306- 4314.
|
|
[17]
|
Lucas, S., Omata, Y., Hofmann, J., et al. (2018) Short-Chain Fatty Acids Regulate Systemic Bone Mass and Protect from Pathological Bone Loss. Nature Communications, 9, Article No. 55. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Chen, F., Wei, Q., Xu, D., et al. (2021) The Associations of Gut Microbiota and Fecal Short-Chain Fatty Acids with Bone Mass Were Largely Mediated by Weight Status: A Cross-Sectional Study. European Journal of Nutrition, 60, 4505- 4517. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Adak, A. and Khan, M.R. (2019) An Insight into Gut Microbiota and Its Functionalities. Cellular and Molecular Life Sciences, 76, 473-493. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Kanazawa, I. (2017) Interaction between Bone and Glucose Metabolism [Review]. Endocrine Journal, 64, 1043-1053. [Google Scholar] [CrossRef]
|
|
[21]
|
Schlesinger, P.H., Blair, H.C., Beer, S.D., et al. (2020) Cellular and Extracellular Matrix of Bone, with Principles of Synthesis and Dependency of Mineral Deposition on Cell Membrane Transport. American Journal of Physiology—Cell Physiology, 318, 111-124. [Google Scholar] [CrossRef] [PubMed]
|